Tag: Investing

Read More

IGC Pharma targets Alzheimer’s market with anti-amyloid drug candidate

IGC Pharma Inc. (NYSE: IGC), which was formerly known as India Globalization Capital, announced Wednesday it plans to advance its drug candidate IGC-AD1 into clinical trials as a potential anti-amyloid treatment for Alzheimer’s disease. The move follows recent FDA approvals of anti-amyloid drugs from Eli Lilly and Eisai/Biogen, signaling growing …

Read More

Whitney Economics slashes U.S. hemp acreage forecast by 82%

Cannabis and hemp business consulting firm Whitney Economics has dramatically reduced its 2030 forecast for U.S. hemp grain and fiber acreage, citing regulatory uncertainties and infrastructural challenges. The firm now projects 1 million acres by 2030, down 82% from its previous estimate. The revision could translate to approximately $3.1 billion …